IP Library Granted Patent US 7,105,511
Granted Patent B2
US 7,105,511 · App. 10/922,300 · Granted Sep 12, 2006

Fluorescent fused-ring triazoles that inhibit cell proliferation and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,105,511
App. No.
10/922,300
Granted
Sep 12, 2006
Kind
B2
Abstract

Fused-ring triazole compounds which inhibit proliferation of cells and exhibit a unique and intense fluorescence are provided. Also provided are methods for synthesizing these compounds and methods for using these compounds to inhibit cell proliferation and infection and to label and fluorescently detect selected molecules.

Claims (20)

1. A compound of Formula II,

wherein R is selected from the group consisting of a furyl, a thienyl, a pyridyl, an alkyl, an aryl or arylalkyl, a 1-(2-phenyl)-ethyl, a 3-methoxyphenyl, a 4-trifluoromethylphenyl and 4-fluorophenyl group.

2. The compound of claim 1 wherein the pyridyl is selected from the group consisting of 2-pyridyl, 3-pyridyl and 4-pyridyl.

3. The compound of claim 1 selected from the group consisting of:

compound IIa,

compound IIb

compound IIc,

compound IId,

compound IIe,

compound IIf,

compound IIg,

compound IIh, and

compound IIi.

4. A one step method for synthesizing the compound of claim 1 comprising adding an α-halocinnamaldehyde to a solution comprising a mercaptoaminotriazole and a tertiary amine and precipitating the compound of Formula II therefrom.

5. A two step method for synthesizing the compound of claim 1 comprising:

(a) deriving a bromocinnamyl imine from condensation of a mercaptoaminotriazole with α-bromocinnamaldehyde; and

(b) refluxing this bromocinnamyl imine with a tertiary amine to produce the compound of Formula II.

6. The method of claim 5 wherein a bromocinnamyl imine is refluxed with triethylamine or pyridine in solvent or with the tertiary amine itself as solvent to effect a ring closure to compounds of Formula II.

7. A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable vehicle.

8. A method for inhibiting a bacterial infection in an animal comprising administering to the animal the pharmaceutical composition of claim 7 .

Assignments (5)
CONFIRMATORY LICENSE Recorded Jul 27, 2021
From: RUTGERS, THE STATE UNIV OF NJ
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 056991/0139 →
NUNC PRO TUNC ASSIGNMENT Recorded Aug 13, 2014
From: THE UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
To: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Reel/Frame 033525/0369 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2005
From: HEINDEL, NED; GUILLON, CHRISTOPHE; DEMATTEO, PETER
To: LEHIGH UNIVERSITY
Reel/Frame 016294/0619 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2005
From: HECK, DIANE
To: RUTGERS, THE STATE UNIVERSITY
Reel/Frame 016294/0667 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2005
From: LASKIN, JEFFREY D.; VETRANO, ANNA MARIE
To: UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
Reel/Frame 016294/0767 →